Impact BioMedical Inc. (IBO) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.5 |
| Open | 0.54 |
| Day High | 0.55 |
| Day Low | 0.53 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.37 |
| Volume | 27,522 |
| Average Volume | 110,388 |
| Market Cap | 6.65M |
| PE | -1.83 |
| EPS | -0.29 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 0.55 |
| Change | 0.03 |
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
GlobeNewswire Inc.
Aug 18, 2025 12:30 PM GMT
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition and Method of Controlling Infectious Diseases with
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
GlobeNewswire Inc.
Jun 23, 2025 11:52 AM GMT
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical
Impact Biomedical Inc. Announcement Stock Activity/Pricing
GlobeNewswire Inc.
Mar 21, 2025 6:38 PM GMT
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no